Inflammation breakthrough offers sepsis hope

A breakthrough in understanding inflammatory diseases offers hope as a treatment for sepsis, Crohn’s disease, psoriasis, and multiple sclerosis.

An international team of researchers, led by scientists at the Human Health Research Institute at Maynooth University, identified a protein that is a key driver of inflammation. Blocking the protein suppresses inflammation and may be a new approach to treating inflammatory diseases.

Inflammatory diseases are difficult to treat, and sepsis, which can kill in just 12 hours, is particularly challenging for healthcare professionals. Sepsis occurs in only 3.4% of hospital cases, according to latest research from the HSE, but contributed to 25% of all hospital deaths.